GE HealthCare Technologies
- Market cap
- 29.21B
- P/E (TTM)i
- 14.90
- P/Bi
- 2.66
- EPSi
- 4.55
- Div yieldi
- 0.22%
- 52W posi
- 19%
Anonymous reader poll. Unscientific, not investment advice.
Shares of GE HealthCare Technologies closed at 64.67, down 0.15%. The company carries a market value of roughly 29.21B, the #689 most valuable US-listed company we track. Trading at a P/E of 15.06, the stock is 23% below its own five-year norm of 19.47. Income-focused holders are looking at a trailing yield of 0.22% here. Across 14 analysts the consensus rating is Buy, with an average price target of 80.71 (+25%). The shares sit 19% of the way up their 52-week range of 58.72 to 89.64.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 9 months.
- Recent price momentum is -6.6% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 3.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 15.1x | Better than 64% |
| Forward P/E | 13.1x | Better than 68% |
| Price / Sales | 1.4x | Better than 76% |
| P/E vs own 5-yr range | 13th pctl | Better than 85% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 4.0% | Better than 38% |
| Net income CAGR (3Y) | 2.8% | Better than 44% |
| Free cash flow CAGR (3Y) | -5.8% | Better than 27% |
Profitability B-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 40.0% | Better than 46% |
| Operating margin | 13.4% | Better than 45% |
| Net margin | 10.1% | Better than 46% |
| Return on equity | 22.1% | Better than 71% |
| Return on invested capital | 12.4% | Better than 65% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 1.4% | Better than 58% |
| 6-month return | -5.7% | Better than 29% |
| 12-month return (ex latest month) | -9.7% | Better than 21% |
| Distance below 52-week high | 26.7% | Better than 34% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.4x | Better than 47% |
| Debt to assets | 28.4% | Better than 52% |
| Interest coverage | 7.3x | Better than 55% |
| Free cash flow / net income | 72.2% | Better than 22% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 71.4% | Better than 48% |
| Upside to average target | 22.8% | Better than 46% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 64.77
- Open
- 64.93
- Day range
- 64.03 - 65.44
- Avg price
- 64.67
- Volume
- 4.07M
- Turnover
- 262.92M
- Turnover ratei
- 0.90%
- Volume ratioi
- 0.90
- Amplitudei
- 2.18%
- 52-week rangei
- 58.72 - 89.64
Valuation
- P/Ei
- 14.21
- P/E (TTM)i
- 14.90
- P/Bi
- 2.66
- EPSi
- 4.55
- Book value / shi
- 24.30
- Net profit
- 2.06B
- Net assets
- 10.98B
Share structure
- Market cap
- 29.21B
- Float capi
- 29.11B
- Shares out
- 451.69M
- Float sharesi
- 450.19M
Dividend & listing
- Div yield (TTM)i
- 0.22%
- Dividend (TTM)
- 0.14
- Listing date
- 2022-12-15
27.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+7.01M net over the window
Short interest
- Shares short
- 16.91M
- % of floati
- 3.74%
- Days to coveri
- 5.54
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of GE HealthCare Technologies (GEHC)?
GE HealthCare Technologies last traded at 64.67. The quote on this page refreshes every few seconds while US markets are open.
What is GE HealthCare Technologies's market cap?
About 29.21B.
What is the P/E ratio of GE HealthCare Technologies?
The trailing twelve-month P/E is 14.90, below its own 5-year average of 19.47 — toward the bottom of its historical range (12.53% percentile). See the Valuation tab for the full history.
Does GE HealthCare Technologies pay a dividend?
Yes. The trailing dividend yield is 0.22%. The 2025 payout was up 16.7% from 2024. See the Dividends tab for the full payment history.
Is GE HealthCare Technologies a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 80.71, which implies 24.8% upside from the current price. This is not investment advice.
What is GE HealthCare Technologies's StockVane Quant Rating?
The StockVane Momentum strategy currently rates GE HealthCare Technologies a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 06:39:23 · For reference only, not investment advice and not tailored to your situation.